Mirum Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MIRM and other ETFs, options, and stocks.

About MIRM

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. 

CEO
Christopher Peetz
CEOChristopher Peetz
Employees
372
Employees372
Headquarters
Foster City, California
HeadquartersFoster City, California
Founded
2018
Founded2018
Employees
372
Employees372

MIRM Key Statistics

Market cap
6.52B
Market cap6.52B
Price-Earnings ratio
-7.87
Price-Earnings ratio-7.87
Dividend yield
Dividend yield
Average volume
871.03K
Average volume871.03K
High today
$107.69
High today$107.69
Low today
$104.36
Low today$104.36
Open price
$104.48
Open price$104.48
Volume
1.46M
Volume1.46M
52 Week high
$114.99
52 Week high$114.99
52 Week low
$47.89
52 Week low$47.89

Stock Snapshot

With a market cap of 6.52B, Mirum Pharmaceuticals(MIRM) trades at $107.13. The stock has a price-to-earnings ratio of -7.87.

During the trading session on 2026-06-20, Mirum Pharmaceuticals(MIRM) shares reached a daily high of $107.69 and a low of $104.36. At a current price of $107.13, the stock is +2.7% higher than the low and still -0.5% under the high.

Trading volume for Mirum Pharmaceuticals(MIRM) stock has reached 1.46M, versus its average volume of 871.03K.

The stock's 52-week range extends from a low of $47.89 to a high of $114.99.

The stock's 52-week range extends from a low of $47.89 to a high of $114.99.

MIRM News

Simply Wall St 2d
Mirum Pharmaceuticals Is Up 8.6% After FDA Grants Priority Review to Zilurgisertib NDA

Mirum Pharmaceuticals and Incyte recently reported pivotal Phase 2 data from the PROGRESS study, showing that oral ALK2 inhibitor zilurgisertib reduced new hete...

Mirum Pharmaceuticals Is Up 8.6% After FDA Grants Priority Review to Zilurgisertib NDA
TipRanks 2d
Mirum Shareholders Approve Directors, Auditors and Compensation

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

Investing.com 5d
Citizens raises Mirum Pharmaceuticals stock price target on drug deal - Investing.com

...

Citizens raises Mirum Pharmaceuticals stock price target on drug deal - Investing.com

Analyst ratings

100%

of 14 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own MIRM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.